Republican U.S. House of Representatives Speaker Mike Johnson said on Wednesday that he believes President Donald Trump is ...

Large American pharmaceutical companies are showing a distinct trend never seen before: they are increasingly looking for ...

Johnson & Johnson and Sanofi said that while the vaccine showed no safety concerns, it did not meet the necessary ...

Pharmaceutical giant Johnson & Johnson (JNJ) is planning to sell its stroke care business called “Cerenovus” for $1 billion ...

Johnson & Johnson — leaders in healthcare innovation, where treatments are smarter and less invasive, and solutions are ...

Zacks.com users have recently been watching Johnson & Johnson (JNJ) quite a bit. Thus, it is worth knowing the facts that could determine the stock's prospects.

A major lawsuit filed on Thursday says pharmaceutical giant Johnson & Johnson has misled customers for decades about the ...

Duato discusses the split of the business, dealing with the scrutiny brought about by lawsuits, and 2025 priorities.

Regeneron initiated a quarterly dividend per share that looks somewhat attractive. Despite some recent issues, the biotech ...

U.S. President Donald Trump’s threats to slap tariffs on medicines could rattle an industry that has become a cornerstone of ...

COUR Pharmaceuticals has been around a while, but not until last year did the company solidify behind its ultimate mission with a series A raise.